Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Risperdal (risperidone) commonly causes weight gain and increased appetite, movement-related effects such as tremor, restlessness, muscle stiffness and, less often, tardive dyskinesia, plus hormone changes from elevated prolactin that can lead to breast enlargement, milk production, missed periods or sexual difficulties. Metabolic shifts in blood sugar and cholesterol may also develop, which is why routine weight, glucose and lipid monitoring matters. Risk varies by dose, age, treatment length and other medications you take, and several of these effects are reversible when caught early. There are important details, warning signs and monitoring tips to consider before assuming a symptom is harmless, so see below for the complete answer.
If you are noticing weight changes, unusual movements, or hormonal symptoms and are unsure whether they are medication related or something else, a free, instant, online symptom check can help you organize what you are feeling, see possible explanations, and decide how urgently to contact your prescriber, all in just a few minutes and without a wait.
Last reviewed for medical accuracy: 09/28/2026
Risperdal (risperidone) is an antipsychotic medication prescribed for conditions such as schizophrenia, bipolar disorder and irritability associated with autism. Like all medications, Risperdal carries potential side effects. Understanding the common risks—especially weight gain, movement disorders and hormonal changes—can help you make informed decisions and manage symptoms effectively.
One of the most frequently reported Risperdal side effects is weight gain. This can occur within weeks to months of starting treatment.
Common patterns
Metabolic risks
Practical tips to manage weight
Risperdal may affect the brain’s movement-regulating pathways, leading to extrapyramidal symptoms (EPS). These can develop early or after long-term use.
Key movement-related side effects
Signs to watch for
Managing movement side effects
Risperdal can increase prolactin levels by blocking dopamine signals in the pituitary gland. Elevated prolactin (hyperprolactinemia) may cause:
In women
In men
General symptoms
What to do
While weight gain, movement problems and hormonal shifts are the most notable, Risperdal can also cause:
Most of these effects improve within days to weeks. If they persist or interfere with daily life, consult your healthcare provider.
Although rare, certain reactions to Risperdal can be life threatening. Seek emergency care or call your doctor if you experience:
For any concerning or unusual symptoms, you can also perform a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Risperdal can be highly effective for managing psychosis, mood swings and irritability. Deciding whether it’s right for you involves weighing potential side effects against therapeutic gains. Here are some steps to consider:
Every individual reacts differently to medication. If you notice troubling weight changes, movement issues or hormonal symptoms, don’t wait. Speak with your doctor about:
Medication decisions should always be made in partnership with a healthcare professional. Never stop or change your dose without medical supervision.
Disclaimer: This information is intended to help you understand potential risperdal side effects. It does not replace professional medical advice. If you experience any life-threatening or serious side effects, seek immediate medical attention. Always talk to your doctor before making changes to your medication regimen.
(References)
* Levin T, Heresco-Levy U. Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic. Eur Neuropsychopharmacol. 1999 Jan;9(1-2):137-9. doi: 10.1016/s0924-977x(98)00016-9. PMID: 10082239.
* Sechi G, Agnetti V, Masuri R, Deiana GA, Pugliatti M, Paulus KS, Rosati G. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry. 2000 Aug;24(6):1043-51. doi: 10.1016/s0278-5846(00)00123-8. PMID: 11041543.
* Bushe C, Shaw M. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics. J Psychopharmacol. 2007 Sep;21(7):768-73. doi: 10.1177/0269881107078281. Epub 2007 Jul 2. PMID: 17606473.
* Hebebrand J. [Neuroleptic adverse effects with emphasis on weight gain]. Z Kinder Jugendpsychiatr Psychother. 2009 Jul;37(4):321-4. PMID: 20306798.
* Anandarajan T, Tibrewal P, Dhillon R, Bastiampillai T. Hyperprolactinaemia on depot risperidone treated with aripiprazole. Aust N Z J Psychiatry. 2012 Aug;46(8):792-3. doi: 10.1177/0004867412445171. Epub 2012 Apr 23. PMID: 22528973.
* Schmidt M, Sofronescu A, Short B, Nahas Z, Zhu Y. Increased prolactin concentrations in a patient with bipolar disorder. Clin Chem. 2013 Mar;59(3):473-5. doi: 10.1373/clinchem.2011.176925. PMID: 23449699.
* Yatham LN, Beaulieu S, Schaffer A, Kauer-Sant'Anna M, Kapczinski F, Lafer B, Sharma V, Parikh SV, Daigneault A, Qian H, Bond DJ, Silverstone PH, Walji N, Milev R, Baruch P, da Cunha A, Quevedo J, Dias R, Kunz M, Young LT, Lam RW, Wong H. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial. Mol Psychiatry. 2016 Aug;21(8):1050-6. doi: 10.1038/mp.2015.158. Epub 2015 Oct 13. PMID: 26460229; PMCID: PMC4960445.
* Mennella C, Dickstein DP. Metformin-Induced Type 1 Hypersensitivity in a Child with Antipsychotic-Induced Weight Gain. J Child Adolesc Psychopharmacol. 2017 Feb;27(1):106-107. doi: 10.1089/cap.2016.0113. Epub 2016 Aug 22. PMID: 27548055.
* Agapoff JR 4th, Olson DJ, White S, Huynh V. Rapid and Sustained Resolution of Risperidone Associated Hyperprolactinemia and Galactorrhea With Low-Dose Lurasidone. J Clin Psychopharmacol. 2020 Jul/Aug;40(4):410-412. doi: 10.1097/JCP.0000000000001230. PMID: 32555004.
* Middleton B, Albany Z, Kamer A, Kara A. Hemichorea-hemiballismus due to diabetic striatopathy a serious complication of uncontrolled diabetes. BMJ Case Rep. 2024 May 22;17(5). doi: 10.1136/bcr-2023-259046. Epub 2024 May 22. PMID: 38782432; PMCID: PMC11116358.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.